glp 1 pipeline What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care Frontiers | Beyond GLP-1: underexplored

Bie J, Pruszyska-Oszmaek E, Koodziejski P, Leciejewska N, Szczepankiewicz D, Sassek M

Improvement of ventricular function in systolic heart failure patients with oral l-citrulline supplementation

GLP-1 agonists for alcohol use disorder represent an emerging area of research interest, though these medications remain unlicensed for this indication in the UK

And if Amino Asylum was willing to sell metformin this way, what does that tell you about their approach to selling semaglutide, a newer and more complex medication with its own serious potential side effects including blood clot concerns and other risks that require medical monitoring

Domingues M, Casaril AM, Birmann PT, Bampi SR, Lourenco DA, Vieira BM, Dapper LH, Lenardao EJ, Sonego M, Collares T, Seixas FK, Bruning CA, Savegnago L (2019) Effects of a selanylimidazopyridine on the acute restraint stress-induced depressive- and anxiety-like behaviors and biological changes in mice